BSE filing, NSE: ORKLAINDIA. Summary written from the filing by ALFA Finder's alert engine.
Orkla India Ltd: key numbers
- Share price
- ₹507.90
- Market cap
- ₹6,960 Cr
- Revenue (annual)
- ₹2,509 Cr
- Net profit (annual)
- ₹285.7 Cr
- P/E (TTM)
- 23.6×Sector 38.6×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orkla India Ltd
All →Orkla India Management Change
Orkla India's Chairman and Non-Executive Director Atle Vidar Nagel Johansen resigned effective October 26, 2026. He cited other professional commitments and no material reasons.
Orkla India Board Meeting Date
Orkla India Ltd will hold a Board Meeting on November 04, 2026, to approve financial results for the quarter ended September 30, 2026. An analyst call follows.
Orkla India Other Announcement
Orkla India filed its quarterly shareholding pattern for the period ending September 2026, detailing promoter group and public shareholding, as required by SEBI regulations.
Orkla India Price Movement Clarification
Orkla India clarified that a news report linking it to a potential transaction with 'Farmley' is speculative. No definitive proposal exists as of now.
Orkla India Product Launch
MTR launches 8 new sweets products, expanding its portfolio to 27 offerings. The new range includes Mysore Pak and Gulab Jamun variants available across metro cities.
Orkla India Annual General Meeting
Orkla India Limited held its 30th Annual General Meeting on August 19, 2026. The meeting covered resolutions on financial statements and ratification of stock option plans.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date